Recent Analyst Forecasts and Stock Ratings
Neurocrine Biosciences, Inc. FAQ's
Neurocrine Biosciences, Inc. has been rated by research analysts at Canaccord Genuity, H.C. Wainwright, Morgan Stanley, UBS, BMO Capital, Oppenheimer in the past 90 days.